Overview
Daymark Health partners with health plans to take on total cost of care risk and provides value-based, in-home and virtual oncology support to patients and their doctors. Its platform bundles care navigation, 24/7 support, symptom management, behavioral health, and social services, plus early palliative care and a twice-weekly symptom tool, delivered by a hybrid team of nurse practitioners, nurses, social workers, and Health Partners. By tying care delivery to payer contracts, Daymark focuses care outside the clinic to reduce fragmentation and manage costs across the care continuum. Its goal is to improve cancer patient outcomes while lowering total costs for payers and patients, serving about two million Americans diagnosed with cancer each year who spend most time outside traditional clinics.
Work here?Claim your company
Simplify's take
What believers are saying
- October 2026 ASCO data showed 10.4% fewer admissions and 8.1% lower spending.
- Daymark raised $20 million in September 2025, extending runway and expanding sales capacity.
- The 2026 advisory board with MSK and Penn names strengthens payer trust and recruiting.
What critics are saying
- BCBSRI evidence covers 5,432 patients; one payer model can fail to generalize.
- Clinical staffing, 24/7 support, and national nursing coverage create heavy operating leverage.
- If payer savings stall after 2026, Daymark’s risk-based model loses economic justification.
What makes Daymark Health unique
- Dr. Justin Bekelman’s oncology leadership and academic credibility anchor Daymark’s care model.
- Daymark combines in-home, virtual, and early palliative care across treatment gaps.
- Its payer contracts tie supportive oncology directly to total-cost accountability.
Help us improve and share your feedback! Did you find this helpful?